Experts have started thinking more broadly about what puts a person at risk for heart disease, still the leading killer in the U.S.

A breakthrough study reveals that SGLT2 inhibitors, originally for diabetes control, can also improve kidney oxygenation and ...

A research group led by Osaka Metropolitan University has studied how SGLT2 inhibitors, a class of drugs that help the ...

Researchers reveal that spermidine-mediated acetylhypusination of RIPK1 suppresses necroptosis and insulin resistance, ...

Type 2 diabetes can lead to diabetic kidney disease, but a class of drugs that cause the kidneys to remove glucose through urine has been gaining attention. An Osaka Metropolitan University-led ...

While Type 2 diabetes can lead to diabetic kidney disease, researchers from the Osaka Metropolitan University explored the potential of SGLT2 (sodium-glucose cotransporter-2) inhibitors to protect ...

New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...

The number of people living with diabetes worldwide has quadrupled in the past two decades, with 830 million people diagnosed ...

Amidst discrepant SPRINT and ACCORD data, this study confirms the benefits seen in nondiabetics, Shawna Nesbitt says.

This syndrome plays a significant role in elevating the risk of developing cardiovascular diseases, which encompass serious ...

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

We are pleased to announce the progress that ZyVersa has made toward achieving our key near-term development milestones,” stated ...